Noninvasive determinants of pulmonary hypertension in interstitial lung disease

被引:12
作者
Joseph, Phillip [1 ,5 ]
Savarimuthu, Stella [1 ]
Zhao, Jiayi [2 ]
Yan, Xiting [1 ]
Oakland, Hannah T. [1 ]
Cullinan, Marjorie [3 ]
Heerdt, Paul M. [4 ]
Singh, Inderjit [1 ]
机构
[1] Yale New Haven Hosp, Yale Sch Med, Dept Med, Div Pulm, New Haven, CT 06520 USA
[2] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA
[3] Yale New Haven Hosp, Dept Resp Care, New Haven, CT USA
[4] Yale New Haven Hosp, Yale Sch Med, Dept Anaesthesiol, New Haven, CT USA
[5] Yale New Haven Hosp, Yale Sch Med, Dept Med, Div Pulm, New Haven, CT 06511 USA
关键词
cardiopulmonary exercise testing; interstitial lung disease; pulmonary hypertension; NATRIURETIC PEPTIDE LEVELS; INHALED TREPROSTINIL; EXERCISE; VENTILATION; PRESSURE; OBESITY; IMPACT;
D O I
10.1002/pul2.12197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) in interstitial lung disease (ILD) is associated with increased mortality and impaired exertional capacity. Right heart catheterization is the diagnostic standard for PH but is invasive and not readily available. Noninvasive physiologic evaluation may predict PH in ILD. Forty-four patients with PH and ILD (PH-ILD) were compared with 22 with ILD alone (non-PH ILD). Six-min walk distance (6MWD, 223 +/- 131 vs. 331 +/- 125 m, p = 0.02) and diffusing capacity for carbon monoxide (DLCO, 33 +/- 14% vs. 55 +/- 21%, p < 0.001) were lower in patients with PH-ILD. PH-ILD patients exhibited a lower gas-exchange derived pulmonary vascular capacitance (GX(CAP), 251 +/- 132 vs. 465 +/- 282 mL x mmHg, p < 0.0001) and extrapolated maximum oxygen uptake (VO2max) (56 +/- 32% vs. 84 +/- 37%, p = 0.003). Multivariate analysis was performed to determine predictors of VO2max. GX(CAP) was the only variable that predicted extrapolated VO2max among PH-ILD and non-PH ILD patients. Receiver operating characteristic curve analysis assessed the ability of individual noninvasive variables to distinguish between PH-ILD and non-PH ILD patients. GX(CAP) (area under the curve [AUC] 0.85 +/- 0.04, p < 0.0001) and delta ETCO2 (AUC 0.84 +/- 0.04, p < 0.0001) were the strongest predictors of PH-ILD. A CART analysis selected GX(CAP), estimated right ventricular systolic pressure (eRVSP) by echocardiogram, and FVC/DLCO ratio as predictive variables for PH-ILD. With this analysis, the AUC improved to 0.94 (sensitivity of 0.86 and sensitivity of 0.93). Patients with a GX(CAP) <= 416 mL x mmHg had an 82% probability of PH-ILD. Patients with GX(CAP) <= 416 mL x mmHg and high FVC/DLCO ratio >1.7 had an 80% probability of PH-ILD. Patients with GX(CAP) <= 416 mL x mmHg and an elevated eRVSP by echocardiogram >43 mmHg had 100% probability of PH-ILD. The incorporation of GX(CAP) with either eRVSP or FVC/DLCO ratio distinguishes between PH-ILD and non-PH-ILD with high probability and may therefore assist in determining the need to proceed with a diagnostic right heart catheterization and potential initiation of pulmonary arterial hypertension-directed therapy in PH-ILD patients.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension [J].
Joseph L. Simonson ;
Dhwani Pandya ;
Sarah Khan ;
Sameer Verma ;
Harly E. Greenberg ;
Arunabh Talwar .
Sleep and Breathing, 2022, 26 :1711-1715
[42]   Predictors of mortality in interstitial lung disease patients without pulmonary hypertension [J].
Alhamad, Esam H. ;
Cal, Joseph G. .
ANNALS OF THORACIC MEDICINE, 2020, 15 (04) :238-243
[43]   Effect of pulmonary rehabilitation program in patients with interstitial lung disease with or without pulmonary hypertension [J].
Mona Abd Elsalam Taha El Gazzar ;
Wafaa Saleh El Shimy ;
Hanan Mohamed Elsaadany ;
Mohamed Sayed Hantera ;
Basem Ibrahim Elshafey .
The Egyptian Journal of Bronchology, 19 (1)
[44]   The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease Dilemmas in Diagnosis and the Conundrum of Treatment [J].
King, Christopher S. ;
Shlobin, Oksana A. .
CHEST, 2020, 158 (04) :1651-1664
[45]   Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis [J].
Fairley, Jessica L. ;
Hansen, Dylan ;
Ross, Laura ;
Proudman, Susanna ;
Sahhar, Joanne ;
Ngian, Gene-Siew ;
Walker, Jennifer ;
Host, Lauren, V ;
Morrisroe, Kathleen ;
Apostolopoulous, Diane ;
Ferdowsi, Nava ;
Wilson, Michelle ;
Tabesh, Maryam ;
Stevens, Wendy ;
Nikpour, Mandana .
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[46]   Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH) [J].
Kattih, Zein ;
Kim, Ho Cheol ;
Aryal, Shambhu ;
Nathan, Steven D. .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
[47]   Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases [J].
Weitzenblum, Emmanuel ;
Chaouat, Ari ;
Canuet, Matthieu ;
Kessler, Romain .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (04) :458-470
[48]   Pulmonary Rehabilitation and Noninvasive Ventilation in Patients with Hypercapnic Interstitial Lung Disease [J].
Dreher, Michael ;
Ekkernkamp, Emelie ;
Schmoor, Claudia ;
Schoenheit-Kenn, Ursula ;
Winterkamp, Sandra ;
Kenn, Klaus .
RESPIRATION, 2015, 89 (03) :208-213
[49]   Noninvasive diagnostic modalities and prediction models for detecting pulmonary hypertension associated with interstitial lung disease: a narrative review [J].
Arvanitaki, Alexandra ;
Diller, Gerhard Paul ;
Gatzoulis, Michael A. ;
Mccabe, Colm ;
Price, Laura C. ;
Wort, S. John .
EUROPEAN RESPIRATORY REVIEW, 2024, 33 (174)
[50]   Pulmonary hypertension in COPD and interstitial lung diseases [J].
Markart, P. ;
Ghofrani, H. A. ;
Grimminger, F. ;
Guenther, A. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 :S164-S166